Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C

Status unconfirmed · Phase 1

Conditions studied: Hepatitis C Virus Infection, Infection, Herpesvirus 2, Human

In brief

This trial is to determine the safety of valacyclovir in persons with chronic hepatitis C and herpes simplex type 2 infection. Participants will be randomized to valacyclovir or matching placebo. After receiving the initial therapy for eight weeks, the participants will cross over to the alternate therapy for an additional eight weeks. Each treatment period will be separated by a two-week period of daily placebo. The hypothesis is that treatment with valacyclovir will result in a significant reduction in serum levels of hepatitis C virus ribonucleic acid.

Key facts

Study ID

NCT01037621

Run by

G.V. (Sonny) Montgomery VA Medical Center

People needed

50

Starts

2010-04-01

Expected to finish

2012-02-01

Last updated by the study team

2011-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of hepatitis C infection
• Clinical diagnosis of herpes simplex type 2 infection

You may not qualify if…

• HIV infection
• Other forms of chronic liver disease
• Chronic medical conditions
• On immunosuppressive medications

Where it is running

• G.V. Sonny Montgomery VA Medical Center — Jackson, Mississippi, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.